Dr. Orna Dreazen holds a Ph.D in Biochemistry from the Weizmann Institute of Science. Her postdoctoral studies were completed at University of California in Los Angeles. In 1994 she received a diploma in Business Administration from the Tel Aviv University.
Dreazen served in key positions in the industry as well as in public service. She was the Quality Control Manager of Interpharm Laboratories Ltd., and established a startup biotech company, Portaman Pharmaceuticals Ltd. Between 1994 and 2000, she was the General Director of the National Public Health Laboratories of the Ministry of Health and from 2000 to 2008 she served as the General Director of the Israel Laboratory Accreditation Authority. In this capacity, she was involved in many international activities, including taking an active role as a member of the Board of Directors of the International Laboratory Accreditation Cooperation (ILAC), The Arrangement Committee Chairperson, representing ILAC in ISO and WHO, and The Bureau International Poids and Measures (BIPM) managing the metrology, weights and measures around the world. Dr. Dreazen is an expert in Quality and Metrology and was the Chairperson of the Israel Society of Metrology.
Now Dr. Orna Dreazen is the Chairperson of the Board of Directors and CEO of Nextar Chempharma Solutions Ltd.